2mg 5mg 10mg Semaglutide Weight Loss Peptides GLP-1 Injection

Semaglutide 2mg 5mg 10mg Weight Loss Peptides GLP-1 Injection

Semaglutide is a novel peptide drug with broad application prospects. Drugs used to treat type 2 diabetes and obesity. Its efficacy and effects are remarkable, providing many patients with new treatment options.
Firstly, somalutide can significantly reduce blood sugar levels. Semaglutide is a GLP-1 receptor agonist that stimulates insulin secretion and inhibits glucagon secretion by simulating the effect of insulin-like growth factor 1 (GLP-1), thereby increasing the synergistic effect between insulin and glucose and effectively controlling blood sugar.
Secondly, semalutide can also help patients lose weight. It produces weight loss by inhibiting appetite and prolonging the emptying time of the gastrointestinal tract. Compared with conventional hypoglycemic drugs, Semaglutide directly acts on the satiety center of the brain, altering the balance of appetite control, thereby reducing patients' desire for food intake.
In addition, somalutide can also improve pancreatic islets β The function of cells. Type 2 diabetes and pancreatic islets β The decline in cell function is closely related, and somalutide stimulates pancreatic islets β The regeneration and proliferation of cells can improve the function of pancreatic islets, thereby alleviating the symptoms of diabetes.